A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-cigarettes on Smoking Behavior
A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-Cigarettes on Smoking Behavior
Ohio State University Comprehensive Cancer Center
1,500 participants
Apr 10, 2024
INTERVENTIONAL
Conditions
Summary
This clinical trial compares the use of tobacco flavored electronic cigarettes (ECs) vs. non-tobacco flavored ECs vs. nicotine replacement therapy (patches and lozenges) on smoking behavior in current cigarette smokers. ECs may reduce cigarette craving and withdrawal symptoms, increase motivation and confidence to stop cigarette smoking, and decrease cigarette smoking and dependence. By comparing participants' preferred flavor ECs (PEC) to tobacco flavor ECs (TEC) to NRT, researchers hope to determine the effect of EC flavors on appeal and use and learn how ECs affect smoking behaviors and health.
Eligibility
Inclusion Criteria5
- >= 21 years old
- Smoke >= 5 cigarettes per day for the past year
- Willing to use either an EC or NRT
- Read and speak English
- Have a smartphone
Exclusion Criteria12
- Report currently using smoking cessation medications, NRT, or actively seeking treatment for smoking cessation
- Current use of an EC > 4 days a month
- Diagnosed medical conditions of lung disease, asthma, cystic fibrosis, heart disease or chronic obstructive pulmonary disease (COPD)
- Unmanaged (unmedicated and/or without counseling) diagnosis of schizophrenia
- History of cardiac event or distress within the past 3 months
- Currently pregnant, planning to become pregnant within 6 months, or breastfeeding
- High blood pressure not controlled by medications
- Serious angina pectoris or chest pain
- Stroke within the past three months
- Known allergy to propylene glycol or vegetable glycerin
- Serious underlying arrhythmias, irregular heartbeat or abnormal heart rhythm
- Live in same household as another study participant
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Given nicotine patches and nicotine lozenges
Ancillary studies
Given Preferred Flavor e-liquid
Given Tobacco flavored e-liquid
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06260683